Evidence map›Paper›PMID 38567210›Full record

ArticleCureus2024

A Unique Case of Late Presentation Giant Lower Extremity Malignant Melanoma.

Omar Al Zarkali, Amanda Marker, Lakhvir Kaur, Ana VanDerWall

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Omar Al ZarkaliInternal Medicine, HCA Florida Blake Hospital, Bradenton, USA.
Amanda MarkerInternal Medicine, HCA Florida Blake Hospital, Bradenton, USA.
Lakhvir KaurInternal Medicine, HCA Florida Blake Hospital, Bradenton, USA.
Ana VanDerWallMedical Oncology, HCA Florida Blake Hospital, Bradenton, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This case describes a unique presentation of a rare malignancy: giant melanoma. Due to the accessibility of healthcare in the United States, it is unusual for melanomas to grow to massive sizes without clinical intervention. In fact, an in-depth literature review elicited only a handful of similar cases. Giant malignant melanomas are typically defined by a cutoff size of no less than 10 cm in diameter. They often present with distant metastases and are highly invasive. Due to limited yet highly variable presentations, there is no standardized approach to treating this class of melanomas. We present a case with unique features not previously documented in similar cases that was ultimately treated with a novel approach.

Indexed as

cancer immunotherapycutaneous malignancygiant melanomamalignant melanoma metastasisoncology imaging

Identifiers

PMID38567210
PMCPMC10985282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.